Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Journal of the International AIDS Society
|
August 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa
Urvi M Parikh, Lauren D Kudrick, Lisa Levy, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma
Xianhai Huang, Jason Brubaker, Wei Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2005
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists
Michael Berlin, Pauline C Ting, Wayne D Vaccaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
Ghady Haidar, Jana L Jacobs, Kailey Hughes Kramer, et al.
Iscience
|
July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 28, 2021
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
Matthew K Hensley, William G Bain, Jana Jacobs, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Journal of the International AIDS Society
|
August 21, 2025
A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa
Urvi M Parikh, Lauren D Kudrick, Lisa Levy, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma
Xianhai Huang, Jason Brubaker, Wei Zhou, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2005
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists
Michael Berlin, Pauline C Ting, Wayne D Vaccaro, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 20, 2023
Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients
Ghady Haidar, Jana L Jacobs, Kailey Hughes Kramer, et al.
Iscience
|
July 25, 2022
Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Biorxiv : the Preprint Server for Biology
|
February 23, 2022
Potent Neutralization of Omicron and other SARS-CoV-2 Variants of Concern by Biparatopic Human VH Domains
Chuan Chen, James W Saville, Michelle M Marti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 28, 2021
Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
Matthew K Hensley, William G Bain, Jana Jacobs, et al.
Page
of 3